OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $600,000 Invested

2020

University College London+

Fiona Ducotterd, PhD

Restoration of healthy Wnt signalling in the neurovascular unit through inhibition of Notum carboxylesterase activity: a Lead to Preclinical Candidate Program for Alzheimer’s disease.

  • Funding Amount: $600,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Vascular
  • Status: Closed